Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that play a crucial role in oxygen homeostasis. Intratumoral hypoxia and genetic alterations lead to HIF activity, which is a hallmark of solid cancer and is associated with poor clinical outcome. HIF activity is regulated by an evolutionary conserved mechanism involving oxygen-dependent HIFa protein degradation. To identify novel components of the HIF pathway, we performed a genome-wide RNA interference screen in Caenorhabditis elegans, to suppress HIF-dependent phenotypes, like egg-laying defects and hypoxia survival. In addition to hif-1 (HIFa) and aha-1 (HIFb), we identified hlh-8, gska-3 and spe-8. The hlh-8 gene is homologous to the human oncogene TWIST1. We show that TWIST1 expression in human cancer cells is enhanced by hypoxia in a HIF-2a-dependent manner. Furthermore, intronic hypoxia response elements of TWIST1 are regulated by HIF-2a, but not HIF-1a. These results identify TWIST1 as a direct target gene of HIF-2a, which may provide insight into the acquired metastatic capacity of hypoxic tumors.
Introduction
One of the hallmarks of solid cancer development is reduced tissue oxygen tension (hypoxia) within the tumor, encountered when tumors outgrow the surrounding blood supply . Hypoxia is correlated with therapy resistance and enhanced metastatic potential, resulting in poor prognosis in many cancer types (Vaupel and Mayer, 2005) . The hypoxiainducible factor (HIF) transcription factor plays a central role in the molecular response to hypoxia. In human cells, the HIF complex consists of a constitutively expressed b-subunit and an a-subunit, which is regulated by oxygen tension (Semenza, 2004) . In the presence of oxygen, HIFa is hydroxylated on proline residues by prolyl hydroxylases (PHDs). Hydroxylated HIF proteins are substrates for the von Hippel-Lindau (VHL) tumor suppressor protein that acts as an E3-ubiquitin ligase targeting hydroxylated-HIFa for proteasomal degradation. Under hypoxia, HIFa is not hydroxylated and becomes stabilized, dimerizes with HIFb and translocates to the nucleus where it mediates target gene activation. Among HIF target genes are glycolytic genes (for example Phosphoglycerate Kinase 1 (PGK1)) and genes involved in angiogenesis (for example Vascular Endothelial Growth Factor (VEGF)), which are key players in the hypoxic response (Greijer et al., 2005) . The human genome encodes three homologous HIFa proteins, respectively HIF-1, -2 and -3a (Wang et al., 1995; Ema et al., 1997; Gu et al., 1998) and three prolyl hydroxylases (Epstein et al., 2001; Semenza, 2001) . The mechanism of oxygen sensing via the HIF pathway is conserved throughout evolution. The nematode Caenorhabditis elegans (C. elegans) has a single homologue for each component (HIF-1 (HIFa), AHA-1 (HIFb), VHL-1 (VHL) and the dioxygenase EGL-9 that regulates HIF prolyl hydroxylation; Shen and PowellCoffman, 2003) . This reduced complexity of the HIF pathway facilitates genetic analysis. In its natural habitat C. elegans is exposed to variable oxygen tension in the soil. Wild-type animals are capable of maintaining metabolism and reproduction in conditions up to 0.5% oxygen. C. elegans carrying deletions in hif-1 are apparently healthy under standard culture conditions, but exhibit high levels of lethality in 0.5 or 1% oxygen (Jiang et al., 2001; Padilla et al., 2002) . Furthermore, egl-9 mutants have constitutive HIF activity, due to loss of HIF-1 hydroxylation (Epstein et al., 2001) . These mutants are egg-laying defective (Trent et al., 1983) . Eggs are maintained in the gonads where they eventually hatch, resulting in laceration of the vulva, killing the mother, while producing viable offspring. Mutation of both hif-1 and egl-9, suppresses the egg-laying defect, demonstrating that this phenotype is HIF-1 dependent (Bishop et al., 2004) . Because of the ability to conduct genome-wide loss of function analysis using RNAi feeding in C. elegans, we chose to exploit the egl-9 mutant phenotype to uncover novel HIF pathway components.
Using this approach, we identified novel genes required in the EGL-9/HIF-1 pathway and for survival under hypoxia. One of these is hlh-8, a basic helix-loophelix transcription factor involved in C. elegans vulval development (Harfe et al., 1998) . The hlh-8 gene is homologous to the human oncogene TWIST1. We show that TWIST1 is regulated in a HIF-dependent manner under hypoxia in mammalian cells. These findings provide novel insight into how intratumoral hypoxia can promote cancer metastasis (Woelfle et al., 2003) .
Results
Genome-wide screening allows identification of HIF pathway members C. elegans egl-9 mutants display an egg-laying defect, visible by an accumulation of eggs in the animal and no or few laid eggs (Trent et al., 1983) . The egl-9 phenotype is suppressed in hif-1 and egl-9 double mutants, suggesting that HIF-1 pathway members downstream of egl-9 are able to modulate the egl-9 egg-laying defect (Bishop et al., 2004) . We reasoned that we could exploit this epistatic relationship to uncover novel genes in the hypoxic response pathway. First, we tested whether knocking down hif-1 via RNA interference would produce a similar suppression as genetic ablation. Indeed, hif-1 RNAi suppressed the egg-laying phenotype of both egl-9 mutants tested (sa307 and n571) visible by the presence of eggs and larvae in the medium (Figure 1a ). Subsequently, we performed a genome-wide RNAi screen in liquid culture using a RNAi library targeting 86% of C. elegans genes van Haaften et al., 2004) . We identified 137 independent RNAi's that suppressed the egl-9 phenotype (Figure 1b , Supplementary data). These included both RNAi's directed against hif-1 and aha-1, validating our screen.
Furthermore, several genes involved in ubiquitin ligation, like ubc-20 and ubc-21, and genes involved in MAPK and AKT signaling pathways were identified (Figure 1c , Supplementary data).
HIF-1, AHA-1, SPE-8, GSKA-3 and hlh-8 are necessary for hypoxic survival Suppressors of the egl-9 phenotype do not necessarily function in the hypoxia response. Animals with a loss of function mutation in hif-1 are known to adapt poorly to oxygen levels between 0.5 and 2% O 2 (Jiang et al., 2001) . To enrich for genes that function in the hypoxia pathway, we rescreened candidate RNAi's for enhanced sensitivity to hypoxia. Wild-type animals were grown under either normoxic or hypoxic (1% O 2 ) conditions and the amount of viable offspring was determined. Under these conditions, B25% of the wild-type offspring survived prolonged exposure to hypoxia (Figure 2a ). Of the 137 RNAi clones examined, five resulted in a dramatic decrease in viability to less than 1% under hypoxia compared to normoxia ( Figure 2a ). As expected, these RNAi clones included hif-1 and aha-1. In addition, RNAi foods directed against three additional genes (spe-8, gska-3 and hlh-8) were identified. To confirm this, we tested hypoxia sensitivity of available mutant strains for hif-1 and gska-3. Both knockout strains phenocopied hypoxia sensitivity similar to genetic knockdown (Figure 2b ). Hypoxia sensitivity might be explained by defects in hif-1 function, caused either by reduced protein levels (hif-1 RNAi) or reduced activity (aha-1 RNAi). Next, we determined the effect of RNAi on the HIF-1 target gene F22B5.4 (Bishop et al., 2004; Shen et al., 2005) . In control animals, F22B5.4 was induced approximately 200-fold by hypoxia compared to normoxia (Figure 2c ). RNAi against hif-1 and aha-1 almost completely abolished F22B5.4 induction, consistent with their role in HIF-1 mediated transcription. RNAi directed against spe-8, gska-3 or hlh-8 however did not reduce F22B5.4 induction, suggesting that these genes do not regulate F22B5.4 expression. 
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Human hlh-8 homologue TWIST1 is induced by hypoxia Human TWIST1 is homologous to C. elegans hlh-8, as demonstrated by sequence comparison, which shows that the HLH-domain has 59-63% sequence identity to Twist-family members in other species (Harfe et al., 1998; Corsi et al., 2002) . Expression of TWIST1 has been shown to induce metastatic capacity and antiapoptotic activity of human cancer cells (Maestro et al., 1999; Yang et al., 2004) . Hypoxia has been implicated in similar processes ). To study the relationship between TWIST1 and hypoxia, we investigated the expression of TWIST1 mRNA in human cell lines after exposure to hypoxia using a TWIST1-specific TaqMan assay. In cervix carcinoma cells (HeLa), prostate cancer cells (PC3) and colon cancer cells (HCT116), TWIST1 expression was induced four-to eightfold after 24 h of hypoxia (Figures 3a-c) concurrent with PGK1 induction, a validated HIF target (Kress et al., 1998) . In contrast, we could not detect significant TWIST1 induction in human embryonic kidney cells (HEK293T) (Figure 3d ). TWIST1 induction correlated with HIF-2a that was expressed and stabilized under hypoxia in all cell types studied, except for HEK293T cells, which showed no TWIST1 induction ( Figure 3e ).
TWIST1 induction is HIF-2a dependent
To investigate whether TWIST1 induction is mediated by HIF activity, cells were treated with the iron chelator, desferroxiamine (DFO), that inhibits prolyl hydroxylase activity leading to HIFa stabilization (Epstein et al., 2001) . DFO induced both TWIST1 and PGK1 expression in HeLa cells ( Figure 4a ). HIF-1b is the constitutively expressed common component of the HIF transcription complex, and is essential for its activity (Wood et al., 1996) . To address whether hypoxic induction of TWIST1 required HIF activity, we used RNAi to knockdown HIF-1b expression ( Figure 4b ). RNAi against HIF-1b severely reduced hypoxic induction of both PGK1 and TWIST1 expression in HeLa cells (Figures 4c and d ). To study if HIFa was necessary for hypoxic TWIST1 induction, we generated HeLa cell lines with stable knockdown of HIF-1a or HIF-2a ( Figure 4e ). Whereas in HIF-1a knockdown cells, PGK1 and TWIST1 was upregulated in a hypoxia-dependent manner similar to the parental line, HIF-2a knockdown cells upregulated PGK1 but failed to induce TWIST1 mRNA after hypoxia (Figures 4f and g ).
HIF-2a regulates TWIST1 intronic hypoxia response elements
To determine whether HIF induces TWIST1 directly, we screened the genomic TWIST1 sequence for consensus HIF binding elements or HREs (Wang et al., 1995) . We identified two potential HREs, 1(CGCGTG) and 2(TGCGTG), within 6 bp proximity within the only intron of TWIST1, located immediately downstream of the coding region that terminates in exon 1 (Figure 5a ). To test whether HIF was sufficient to induce expression from these sequences, we generated pGL3-based luciferase reporter constructs containing genomic fragments upstream and downstream from the TWIST1 open reading frame (Figure 5a ). A 600 bp sequence 5 0 of the TWIST1 transcript containing the TATA box was not activated by either HIF-1a or HIF-2a (Figures 5b, d and e). In contrast, reporter constructs containing the potential HREs in the 3 0 -intronic sequence were induced in a dose-dependent manner by HIF-2a, but not by HIF-1a, whereas a VEGF-derived HRE reporter was induced by both HIF-1a and HIF-2a (Figures 5c-e) . Importantly, mutating either HRE 1 or 2 completely abolished TWIST1-reporter activity, demonstrating that both HREs are essential for TWIST1 regulation by HIF-2a. Erbel et al., 2003) . Wild-type HIF-2a induced both 3 0 TWIST1 and VEGF reporter activity. In contrast, overexpression of HIF-2a-D1-278 mutant did not result in 3 0 TWIST1 and VEGF reporter activity (Figures 6c and d) . In addition, overexpression of the HIF-2a DNA-binding domain alone (HIF-2a-D281-870) did not induce the 3 0 TWIST1 reporter activity (data not shown). These results demonstrate that HIF-2a DNA binding is necessary for TWIST1 induction, appointing to a direct interaction of HIF-2a with the 3 0 TWIST1 HREs.
Discussion
Tumor hypoxia is a common event in solid cancer progression and leads to aggressive tumors that are highly angiogenic and are associated with treatment failure and poor clinical prognosis (Semenza, 2003) . Because hypoxia is encountered early during cancer cell expansion, tumor hypoxia is a relevant therapeutic target. The HIF-VHL axis is essential in the hypoxic response of tumor cells and highly conserved throughout evolution (Jiang et al., 2001; Dekanty et al., 2005) . Over expression of both HIF-1a and HIF-2a is seen in many human cancers (Semenza, 2003) . Although the HIF-1a and HIF-2a proteins are very similar and are both induced upon hypoxia, they elicit different transcriptional responses and have different roles during embryonic development (Ravi et al., 2000; Wiesener et al., 2003; Raval et al., 2005; Wang et al., 2005) .
In this study, we performed a genome-wide loss of function screen to identify novel components of the HIF pathway in C. elegans and validated their role in hypoxia response in mammalian (cancer) cells. We uncovered a total of 137 C. elegans genes that in one or both egl-9-deficient strains suppressed the egg-laying defect. These genes could be categorized according to (Figure 1c , Supplementary data). In addition to hif-1 and aha-1, we found akt-2, a homologue of the human AKT oncoprotein, which is involved in regulation of HIF-1a protein expression (Bardos and Ashcroft, 2004; Dekanty et al., 2005; Gort et al., 2006) . Furthermore, an unknown protein (Y39A3CR.6, Supplementary data) with significant homology to mammalian HIF-1b-like protein was found (Ikeda and Nomura, 1997) . Although the egl-9 mutant phenotype is HIF-1 dependent, the etiology is more complicated, since vhl-1-deficient worms have comparable HIF-1 levels, but are not egg-laying defective (Shen et al., 2006) . This points to a TWIST1 is a target of HIF-2a EH Gort et al 
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EH Gort et al VHL-independent regulation of HIF activity by EGL-9. Indeed, in addition to its role in regulating HIF protein stability through hydroxylation, the human EGL-9 homologue EGLN1 also suppresses HIF transcription in the nucleus . This may in part explain the higher transcriptional activity of HIF target genes and the more severe phenotype of egl-9-deficient animals (Shen et al., 2006) . Furthermore, EGL-9 and the recently identified HIF-1 regulator RHY-1 function in a VHL-1-independent pathway to repress HIF-1 activity, which can explain a VHL-1-independent function of EGL-9 (Shen et al., 2006) . To enrich for HIF-1-dependent genes from the primary candidates, we performed an additional selection using a hypoxia survival assay. Using this assay we recovered both hif-1 and aha-1, demonstrating that AHA-1 is necessary for HIF-1-mediated transcription and HIF-1-dependent phenotypes (Jiang et al., 2001 ). We identified three novel genes previously unknown to play a role in the C. elegans HIF pathway. Two of these, spe-8 and gska-3, are predicted homologues of the human tyrosine kinase FER and the serine/threonine glycogen synthase kinase GSK-3 respectively, which have previously been reported to play a role in HIF regulation in mammalian cells (Mottet et al., 2003; Salem et al., 2005) . Using gska-3-deficient animals, we confirmed increased hypoxia sensitivity observed with gska-3 knockdown. We were unable to demonstrate reduced HIF-1 target gene expression, suggesting these genes function downstream or parallel to hif-1, or are regulated in a spatially or temporally restricted manner that impeded robust detection. In addition, we identified hlh-8, the C. elegans homologue of human oncogene TWIST1 (Harfe et al., 1998) . HLH-8 is involved in C. elegans vulval development, which might explain its role in egg-laying defects (Harfe et al., 1998) .
In mammalian cells, we show that TWIST1 expression is induced by hypoxia, which requires HIF function. Furthermore, we show that HIF-2a, but not HIF-1a, regulates TWIST1 expression through intronic HREs 3 0 of the TWIST1 coding sequence. Regulation of 3 0 sequences by the HIF transcription complex are not unusual. Indeed, one of the best characterized HIF target genes, erythropoietin, is regulated via 3 0 HRE sequences (Pugh et al., 1991; Wang and Semenza, 1993) . Nevertheless, we cannot exclude additional regulation of TWIST1 via other unidentified HREs.
TWIST1 belongs to a family of bHLH transcription factors that regulates mesodermal cell fate in Drosophila (Szymanski and Levine, 1995) . Loss of TWIST1 expression is associated with the hereditary SaethreChotzen syndrome that is characterized by inappropriate fibroblast growth factor receptor 2 (FGFR2) expression (Wilkie and Morriss-Kay, 2001 ). TWIST1 acts as an inhibitor of N-MYC-induced apoptosis, establishing TWIST1 as an oncogene (Maestro et al., 1999) . In human breast cancers, high TWIST1 levels correlate with invasive lobular carcinoma, a highly infiltrating tumor type associated with loss of E-cadherin expression and required for breast cancer metastases in a murine model for breast cancer (Yang et al., 2004) . TWIST1 represses E-cadherin, which results in the activation of mesenchymal markers and cell motility suggesting that TWIST1 promotes epithelial-to-mesenchymal transition. TWIST1 may also regulate the expression of the bHLH repressor SNAIL that acts as a boundary repressor by downregulating the expression of ectodermal genes within the mesoderm (Ip et al., 1992) . The HIF pathway can also regulate E-Cadherin repression, presumably via SNAIL (Esteban et al., 2006) . Our data suggest that this might be in concert with TWIST1.
Hypoxia-induced TWIST1 expression illustrates how cells can acquire phenotypic characteristics like increased motility, scattering and invasiveness associated with aggressive tumor behavior (Hanahan and Weinberg, 2000) . Interestingly, HIF-2a has been shown to enhance aggressive tumor behavior (Kondo et al., 2003; Holmquist-Mengelbier et al., 2006) . This is consistent with HIF-2a-dependent regulation of TWIST1 as shown here. Possibly, HIF-2a controls gene expression in (hypoxia-induced) metastatic disease, whereas HIF1a plays a more prominent role during normal oxygen homeostasis. This is supported by the finding that HIF-1a does not induce metastasis formation in a transgenic mouse model, but does facilitate this process (Liao et al., 2007) . The regulation of TWIST1 by the HIF pathway in mammalian cells provides an attractive explanation for the poor survival seen in patients with HIF overexpression (Bos et al., 2003) . It will be interesting to study TWIST1 expression in hypoxic tumor models and relate this to metastatic propensity.
Materials and methods
Strains and C. elegans culturing Standard C. elegans culturing methods were used. The following C. elegans strains were used: wild-type Bristol N2, ZG31 hif-1(ia4), JT307 egl-9(sa307), MT1201 egl-9(n571) and RB1034 gska-3(ok970) (source Caenorhabditis Genetics Center, and C. elegans knock-out consortium (RB1034)). Strains were maintained at 20 1C.
RNA interference (RNAi) was performed by feeding worms Escherichia coli strain HT115 (DE3) expressing doublestranded (ds) RNA. Plasmids for dsRNA production were derivatives of the L4440 vector and were obtained from J Ahringer (Cambridge, UK).
RNAi screen in liquid 96-well culture Inoculation and induction of bacteria and high throughput screening in liquid culture was done as previously described (Kamath and Ahringer, 2003; van Haaften et al., 2004) . Worm cultures were synchronized by bleaching and hatched in M9 at 20 1C overnight. For RNAi liquid cultures 20-30 L1 larvae were resuspended in 50 ml of M9 per well in flat-bottom 96-well tissue-culture plates and 75 ml of bacteria were added. The egg-laying defective phenotype is thermosensitive and therefore, animals were cultured at 25 1C (Trent et al., 1983) . Per RNAi, 25 synchronized L1 larvae from one of both egl-9-defective strains (sa307 and n571) were cultured. Occurrence of F 1 (eggs and larvae) was determined between 48 and 72 h of growing under permissive conditions of 25 1C. Addresses displaying progeny after 48 h in one or both strains and/or after 72 h in both strains were marked positive and verified by sequencing.
Hypoxia sensitivity assay
RNAi bacteria from an overnight culture in Luria broth medium containing 50 mg ml À1 ampicillin were induced with 0.25 mg ml À1 isopropylthiogalactoside at 37 1C for 4 h and then seeded on 4-cm nematode growth-medium RNAi plates containing 50 mg ml À1 ampicillin and 200 mg ml À1 isopropylthiogalactoside. Roughly 30 synchronized L1 larvae (P 0 ) were seeded on fresh RNAi plates and incubated for 24 h at 25 1C under 20% oxygen. Subsequently, the plates were exposed to hypoxia (1% O 2 ) in an in vivo 1000 hypoxia workstation (Ruskin Technology, Leeds, UK) for 120 h at 25 1C. The amount of viable offspring (F 1 ) was determined.
Cell culturing, transfection and luciferase assay HeLa cells, PC3 cells, HCT116 cells and HEK293T cells were cultured in Dulbecco's modified Eagle's medium (Gibco BRL, London, UK) supplied with 10% fetal calf serum (FCS) and antibiotics (Gibco BRL). When indicated, cells were exposed to hypoxia (1% O 2 ) using the hypoxic workstation. HeLa cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. HEK293T were transfected using polyethylenimine (Polysciences, Washington, PA, USA). Stable cell lines were generated by infection of HeLa cells expressing an ecotropic receptor with supernatant from Phoenix cells transfected with pRetroSuper containing hairpin sequences directed against either HIF-1a or HIF-2a. Polyclonal lines were cultured continuously under 2 mg ml À1 puromycin. For luciferase reporter assays, cells were lysed in passive lysis buffer (Promega Corporation, Madison, WI, USA) according to the manufacturer's protocol. Experiments were performed in triplicate. Samples were assayed with a dual luciferase kit (Promega Corporation) and measured using a VeritasTM 96-well plate luminometer (Turner Biosystems, Sunnyvale, CA, USA). All values were normalized using TK-Renilla (Promega Corporation) expression.
Cloning, plasmids and RNAi
The 5 0 intronic region of TWIST1 was cloned by PCR on genomic DNA using forward primer (1); 5 0 -GCGCCATT GCTGCTGTCAC-3 0 , and reverse primer (2); 5 0 -GGACGG ACGGGAGGGACC-3 0 . The 3 0 intronic region of TWIST1 was cloned by PCR on genomic DNA using forward primer (3); 5 0 -CAGTCCACCTCGATTTCCTC-3 0 , and reverse primer (4); 5 0 -GTGACCCTGGGTGTCTCTGT-3 0 . Products were subcloned from pCR2.1 (Invitrogen) into pGL3-prom (Promega Corporation) using KpnI and XhoI (Roche, Basel, Switzerland). Base-pair substitutions were constructed by PCR on plasmid DNA using (A) forward primer (3) and reverse primer (5); 5 0 -CCTGTCACGCACACTCAAACGCA C-3 0 , or reverse primer (6); 5 0 -CCTGTCAAACACACTCA CGCGCAC-3 0 , and (B) forward primer (7); 5 0 -GTGCGTT TGAGTGTGCGTGACAGG-3 0 , or forward primer (8); 5 0 -GTGCGCGTGAGTGTGTTTGACAGG-3 0 and reverse primer (4). The fragment obtained after PCR on PCR products A and B using forward primer (3) and reverse primer (4) was subcloned as described above. All constructs were verified by sequencing. The expression plasmids pCEP4-HIF-1a and pcDNA3-HIF-2a and the 5xHRE/hCMVmp-luc reporter construct were previously described (Forsythe et al., 1996; Tian et al., 1997; Shibata et al., 1998) . Full-length HIF-2a-Flag was constructed by digestion of pcDNA3-HIF-2a using BamHI and cloning into the p3XFLAG-CMVt-10 expression vector (Sigma, St Louis, MO, USA). This plasmid was then EcoRI digested and the removed fragment was replaced by a PCR-derived fragment from pcDNA3-HIF-2a using primers forward 5 0 -CGCGAATTCATGACAGCTGACAAGGAGAA GAAAAGGAG-3 0 and reverse 5 0 -TGGTAGAATTCATAGG CTGAGCGGCCAAGCAGCTC-3 0 . Next, the plasmid was HindIII digested and overhangs were filled in with Klenow and backligated, resulting in HIF-2a-Flag. HIF-2a-FlagD1-278 was generated by digestion of the HIF-2a-Flag construct using EcoRI and subsequent backligation, losing the EcoRI fragment. The HIF-2a DNA binding domain construct (HIF-2a-D281-870) contains amino acid 1-280, encompassing the bHLH domain and part of the PAS domain. Short interfering RNA oligos were obtained from Ambion (CA, USA); siRNA ID #114178 (HIF-1b), #114177 (HIF-1b), #147201 (HIF-1b) and Silencer negative control #1 siRNA. Knockdown plasmids were generated by ligation of annealed oligo sequences 5 0 -GATCCCCGGACAAGTCACCACAGGACTTCAAGAGA GTCCTGTGGTGACTTGTCCTTTTTGGAAA-3 0 and 5 0 -A GCTTTTCCAAAAAGGACAAGTCACCACAGGACTCTC TTGAAGTCCTGTGGTGACTTGTCCGGG-3 0 for HIF-1a and 5
0 -GATCCCCGGAGACGGAGGTGTTCTATTTCAAGA GAATAGAACACCTCCGTCTCCTTTTTGGAAA-3 0 and 5 0 -AGCTTTTCCAAAAAGGAGACGGAGGTGTTCTATTCTC TTGAAATAGAACACCTCCGTCTCCGGG-3 0 for HIF-2a into BglII-and HindIII-digested pRetroSuper-puro (kindly provided by Dr Reuven Agami, Netherlands Cancer Institute, Amsterdam).
RNA analysis
RNA from total worm lysate and total mammalian cell lysate was prepared by homogenation in Trizol reagent (Invitrogen) followed by chloroform/phenol extraction. cDNA was prepared from 1 mg of RNA using Reverse Transcriptase (Roche) and oligo-(dT) primers (Invitrogen). Quantitative PCR for C. elegans genes was performed using SYBR green (Applied Biosystems, Foster City, CA, USA). Specific primer sequences for F22B5.4 and inf-1 were kindly provided by Dr PowellCoffman (Shen et al., 2006) . Q-PCR for human genes was performed using commercially available TaqMan assays for PGK1 (Hs99999906_m1), TWIST1 (Hs00361186), and hydroxymethylbilane synthase (HMBS; Hs00609297_m1; Applied Biosystems) using an ABI7900 analyzer (Applied Biosystems). Data were analysed using the SDS2.2.1 program (Applied Biosystems). HMBS was used for normalization.
Western blotting A measure of 20 mg protein per lane was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by western blot analysis. The following antibodies were used; anti-HIF-1a and anti-HIF-1b (BD Biosciences, San Jose, CA, USA), anti-HIF-2a (NOVUS Biologicals, Littleton, CO, USA), anti-Flag M2 (Sigma), antib-actin (US Biological), goat anti-mouse IgG þ IgM HRP conjugate (Biosource, Camarillo, CA, USA) and goat antirabbit IgG HRP conjugate (Biorad, Hercules, CA, USA). Enhanced Chemo Luminescence (ECL, Amersham Biosciences, Piscataway, NJ, USA) was used for signal detection according to the manufacturer's protocol.
